Hyun Ah Yoon
<div id="cit_full" class="meta">
<p class="j"> </p>
</div>
<div class="ab"> </div>
<div id="cit_full" class="meta">
<p class="j"> </p>
</div>
<div class="ab"> </div>
<p>Benedict (Benny) Wu, DO, PhD, is the Director of Inpatient Dermatology and Assistant Professor at Montefiore-Einstein. Dr. Wu’s clinical interests extend to inpatient and complex medical dermatology areas, including connective tissue disorders, autoimmune bullous disorders, immunodermatology, cutaneous presentation of systemic conditions, and cutaneous lymphomas.</p>
<p>After earning his Bachelor of Science in biological sciences from the University of California, Irvine, Dr. Wu attended the University of Medicine and Dentistry of New Jersey, earning his Master of Biomedical Sciences. He later attended Rowan University, earning his Doctor of Philosophy in Cell and Molecular Biology in 2014 and his Doctor of Osteopathic Medicine in 2016. His postdoctoral training began with an internship in internal medicine at Drexel University College of Medicine, followed by a clinical research fellowship at Northwestern University. In 2021, he completed his Dermatology residency at Broward Health in Fort Lauderdale, Florida.</p>
<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;"> Dr. Wu’s clinical interests extend to inpatient and complex medical dermatology areas, including connective tissue disorders, autoimmune bullous disorders, immunodermatology, cutaneous presentation of systemic conditions, and cutaneous lymphomas.</span>
<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Wu’s research investigates several questions. His research focus spans from his work in the clinic to the basic sciences. For example, does physical and/or emotional stress significantly exacerbate complex medical dermatoses? In the future, he hopes to examine neutrophil dysfunction at the cellular and molecular level from tissue and blood samples from neutrophil-predominant dermatoses.</span>
<p><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif; color: #212121;">Hopkins ZH, Wu BC, Nousari CH. Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. </span><em><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif; color: #212121;">N Engl J Med</span></em><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif; color: #212121;">. 2021;385(11):1055-1056. doi:10.1056/NEJMc2111763</span></p>
<p><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif; color: #212121;">Nousari Y, Wu BC, Tausk F. From the Caravels to the Wards: Scurvy and Schizophrenia [published online ahead of print, 2021 Jun 8]. <em>J Acad Consult Liaison Psychiatry</em>. 2021;S2667-2960(21)00097-5. doi:10.1016/j.jaclp.2021.05.006</span></p>
<p><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif;">Nousari Y, Wu BC, Valenzuela G. Successful use of baricitinib in the treatment of refractory rheumatoid arthritis-associated Sweet syndrome [published online ahead of print, 2021 Apr 29]. <span class="em" style="border: none; vertical-align: baseline;"><em><span style="border: none;"><span style="border: none;">Clin Exp Dermatol</span></span></em></span>. 2021;10.1111/ced.14712. doi:10.1111/ced.14712</span></p>
<p><span style="font-size: 11pt; font-family: 'Century Gothic', sans-serif;">Erickson, T. R., Murphrey, M. B., Abu-Zayed, H., Wu, B., Ibler, E., Rangel, S. M., & Paller, A. S. (2020). Transepidermal water loss in the orphan forms of ichthyosis. <span class="em" style="border: none; vertical-align: baseline;"><em><span style="border: none;"><span style="border: none;">Pediatric dermatology</span></span></em></span>, <span class="em" style="border: none; vertical-align: baseline;"><em><span style="border: none;"><span style="border: none;">37</span></span></em></span>(4), 771–773. https://doi.org/10.1111/pde.14221</span></p>
<p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Benedict (Benny) Wu, DO, PhD, is the Director of Inpatient Dermatology and Assistant Professor at Montefiore-Einstein. Dr. Wu’s clinical interests extend to inpatient and complex medical dermatology areas, including connective tissue disorders, autoimmune bullous disorders, immunodermatology, cutaneous presentation of systemic conditions, and cutaneous lymphomas.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">After earning his Bachelor of Science in biological sciences from the University of California, Irvine, in 2006, Dr. Wu attended the University of Medicine and Dentistry of New Jersey, earning his Master of Biomedical Sciences in 2007. He later attended Rowan University, earning his Doctor of Philosophy in Cell and Molecular Biology in 2014 and his Doctor of Osteopathic Medicine in 2016. His postdoctoral training began with an internship in internal medicine at Drexel University College of Medicine in 2017, followed by a clinical research fellowship at Northwestern University in 2018. In 2021, he completed a three-year dermatology residency at Broward Health.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Wu’s research investigates several questions. His research focus spans from his work in the clinic to the basic sciences. For example, does physical and/or emotional stress significantly exacerbate complex medical dermatoses? In the future, he hopes to examine neutrophil dysfunction at the cellular and molecular level from tissue and blood samples from neutrophil-predominant dermatoses. He has shared his research in many oral and poster presentations, as well as in peer-reviewed publications.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Wu is a member of several professional societies, including the American Academy of Dermatology, the Medical Dermatology Society, the Society for Dermatological Hospitalists, and the Society for Investigative Dermatology.</p>
<p>Dr. Weston’s research interests include the epidemiology, mechanisms of resistance, and therapy of multi-drug resistant gram-negative infections, particularly Carbapenem-Resistant Enterobateriaceae. He works with mathematical modeling techniques to predict which patients are at high risk of CRE bloodstream infections. He also organizes Montefiore’s participation in the CRACKLE II multicenter database of CRE infections.</p>
<p>Dr. Weston’s inpatient clinical work is on a service dedicated to infectious disease consultation in the intensive care and step down units of Weiler hospital. This includes brief daily rounds with each unit to identify needs for consultation and provide antibiotic stewardship guidance. He is a member of the Montefiore Antibiotic Stewardship Team and also sees patients in an Outpatient Parenteral Antibiotic Therapy clinic.</p>
<p>Dr. Weston is a graduate of Regis High School in New York. He received his undergraduate education summa cum laude from the College of the Holy Cross in Worcester, Massachusetts. He received a medical degree from the College of Physicians and Surgeons of Columbia University in New York. He completed Internal Medicine residency at the Emory University School of Medicine in Atlanta, Georgia. Dr. Weston joined Montefiore Medical Center and the Albert Einstein College of Medicine in 2013 for his fellowship in Infectious Diseases. During Fellowship he completed a Master’s of Science in Clinical Research degree in the Einstein Clinical Research Training Program. </p>
<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/28167547">Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.</a> Satlin MJ, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG, Hamula CL, Uhlemann AC, Levi MH, Fries BC, Tang YW, Juretschko S, Rojtman AD, Hong T, Mathema B, Jacobs MR, Walsh TJ, Bonomo RA, Kreiswirth BN. <em>Antimicrobial Agents and Chemotherapy</em> 2017; 61: e02349-16</p>
<p>A multicenter study measuring appropriateness of carbapenem use. Weston G, Jacob JT, Ray S, Varkey J, Gaynes RP. Infection Control and Hospital Epidemiology 2013; 34: 1324-1326</p>
<p><em><span style="text-decoration: underline;">Toxoplasma gondii</span></em>, microsporidiosis, stage differentiation, polar tube structure and function</p>
<p><strong>Toxoplasmosis:</strong> <em>Toxoplasma gondii</em> is a ubiquitous Apicomplexan protozoan parasite that infects humans, mammals and birds. Despite recent progress in understanding the biology of the rapidly replicating form (tachyzoite), very little is known about the cyst form (bradyzoite). The bradyzoite stage plays a critical role in maintenance of latent infection, the relapse of infections and the development of chronic neurologcial disease. Our research is focused on the identification of cyst wall (bradyzoite) proteins and how they function. </p>
<p><strong>Microsporidiosis:</strong> The phylum Microspora consists of organisms collectively known as microsporidia, that are "emerging" human and veterinary pathogens. A microsporidian-specific organelle, the polar tube, is involved in invasion. While the description of the polar tube as a unique microsporidian structure occurred over 100 years ago, the biochemical components of this structure and the mechanism of its formation during invasion remain to be definitively determined. The laboratory is focused on projects invovling the: (1) characterization of the structure and composition of the polar tube and spore wall, and (2) the identificiation of therapeutic targets for the treatment of microsporidiosis. </p>
Treatment and diagnosis of infectious diseases, with a focus on parasitology and global health.
Investigates the biology of Toxoplasma gondii and its ability to cause latent infections, with a focus on the composition and structure of the T. gondii tissue cyst.
<p>Mayoral J, Guevara RB, Rivera-Cuevas Y, Tu V, Tomita T, Romano JD, Gunther-Cummins L, Sidoli S, Coppens I, Carruthers VB, Weiss LM. Dense Granule Protein GRA64 interacts with host cell ESCRT proteins during <em>Toxoplasma gondii</em> infection.mBio. 2022 Jun 22:e0144222. doi: 10.1128/mbio.01442-22.</p>
<p>Tomita T, Mukhopadhyay D, Han B, Yakubu R, Tu V, Mayoral J, Sugi T, Ma Y, Saeij JPJ, Weiss LM. <em>Toxoplasma gondii</em> matrix antigen 1 is a secreted immunomodulatory effector. mBio. 2021 May 18;12(3):e00603-21. </p>
<p>Flores J, Takvorian PM, Weiss LM, Cali A, Gao N. Human microsporidian pathogen <em>Encephalitozoon intestinalis</em> impinges on enterocyte membrane trafficking and signaling. J Cell Sci. 2021 Feb 15:jcs.253757. doi: 10.1242/jcs.253757.</p>
<p>Mayoral J, Tomita T, Tu V, Aguilan JT, Sidoli S, Weiss LM. <em>Toxoplasma gondii</em> PPM3C, a secreted protein phosphatase, affects parasitophorous vacuole effector export. PLoS Pathog. 2020 Dec 28;16(12):e1008771. doi: 10.1371/journal.ppat.1008771. </p>
<p>Mayoral J, Shamamian P Jr, Weiss LM. In Vitro Characterization of protein effector export in the bradyzoite stage of Toxoplasma gondii. mBio. 2020 Mar 10;11(2). pii: e00046-20. doi: 10.1128/mBio.00046-20. PMID: 32156805</p>
<p><span lang="EN">Tu V, Tomita T, Sugi T, Mayoral J, Han B, Yakubu RR, Williams T, Horta A, Ma Y, Weiss LM. The <em>Toxoplasma gondii</em> cyst wall interactome. mBio. 2020 Feb 4;11(1). pii: e02699-19. doi: 10.1128/mBio.02699-19.PMID: 32019789</span></p>
<p>Tu V, Mayoral J, Yakubu RR, Tomita T, Sugi T, Han B, Williams T, Ma Y, Weiss LM.MAG2, a <em>Toxoplasma gondii</em> bradyzoite stage-specific cyst matrix protein. mSphere. 2020 Feb 19;5(1). pii: e00100-20. doi:10.1128/mSphere.00100-20.PMID: 32075884</p>
<p><span lang="EN">Han B, Ma Y, Tu V, Tomita T, Mayoral J, Williams T, Horta A, Huang H, Weiss LM Microsporidia interact with host cell mitochondria via voltage-dependent anion channels using sporoplasm Surface Protein 1. mBio. 2019 Aug 20;10(4). pii: e01944-19. doi: 10.1128/mBio.01944-19. PMID: 31431557</span> <span lang="EN">PMC6703431</span></p>
<p><span lang="EN">Takvorian PM, Han B, Cali A, Rice WJ, Gunther L, Macaluso F, Weiss LM. An ultrastructural study of the extruded polar tube of<em> Anncaliia algerae</em> (Microsporidia). J Eukaryot Microbiol. 2019 Jul 22. doi: 10.1111/jeu.12751. PMID: 31332877</span></p>
<p><span lang="EN">Tomita T, Wang H, Wu P, Weiss LM.Stage-specific and selective delivery of caged azidosugars into the intracellular parasite <em>Toxoplasma gondii</em> by using an esterase-ester pair technique. mSphere. 2019 May 29;4(3). pii: e00142-19. doi: 10.1128/mSphere.00142-19. PMID: 31142619</span></p>
<p>Tu V, Mayoral J, Sugi T, Tomita T, Han B, Ma YF, Weiss LM. Enrichment and proteomic characterization of the cyst wall from in vitro <em>Toxoplasma gondii</em> cysts. mBio. 2019 Apr 30;10(2). pii: e00469-19. doi: 10.1128/mBio.00469-19. PMID: 31040239</p>
<p>Sugi T, Tu V, Ma Y, Tomita T, Weiss LM. <em>Toxoplasma gondii</em> requires glycogen phosphorylase for balancing amylopectin storage and for efficient production of brain cysts. mBio. 2017 Aug 29;8(4). pii: e01289-17. doi: 10.1128/mBio.01289-17.PMID: 28851850 PMC5574715</p>
<p>Yakubu RR, Silmon de Monerri NC, Nieves E, Kim K, Weiss LM. Comparative Monomethylarginine proteomics suggests that protein arginine methyltransferase 1 (PRMT1) is a significant contributor to arginine monomethylation in <em>Toxoplasma gondii</em>. Mol Cell Proteomics. 2017 Apr;16(4):567-580. doi: 10.1074/mcp.M117.066951. Epub 2017 Jan 31.PMID: 28143887</p>
<p>Han B, Polonais V, Sugi T, Yakubu R, Takvorian PM, Cali A, Maier K, Long M, Levy M, Tanowitz HB, Pan G, Delbac F, Zhou Z, Weiss LM. The role of microsporidian polar tube protein 4 (PTP4) in host cell infection. PLoS Pathog. 2017 Apr 20;13(4):e1006341. doi: 10.1371/journal.ppat.1006341. eCollection 2017 Apr. PMID: 28426751</p>
<p>Sugi T, Ma YF, Tomita T, Murakoshi F, Eaton MS, Yakubu R, Han B, Tu V, Kato K, Kawazu S, Gupta N, Suvorova ES, White MW, Kim K, Weiss LM. Toxoplasma gondii cyclic AMP-dependent protein kinase subunit 3 is involved in the switch from tachyzoite to bradyzoite development. mBio. 2016 May 31;7(3). pii: e00755-16. doi: 10.1128/mBio.00755-16. PMID: 27247232 PMCID: PMC4895117</p>
<p>El Bissati K, Suvorova ES, Xiao H, Lucas O, Upadhya R, Yan Fen Ma YF, Hogue Angeletti R, White MW, Weiss LM, Kim K <em>Toxoplasma gondii</em> arginine methyltransferase 1 (PRMT1) regulates centrosome dynamics during tachyzoite cell division. mBio. 2016 Feb 2;7(1):e02094-15. doi: 10.1128/mBio.02094-15. PMID: 26838719 PMCID: PMC4742710</p>
<p>Silmon de Monerri NC, Yakubu RR, Chen AL, Bradley PJ, Nieves E, Weiss LM, Kim K. The Ubiquitin proteome of <em>Toxoplasma gondi</em>i reveals roles for protein ubiquitination in cell-cycle transitions. Cell Host Microbe. 2015 Nov 11;18(5):621-33. doi: 10.1016/j.chom.2015.10.014. PMID: 26567513</p>
<p>Tomita T, Bzik DJ, Ma YF, Fox BA, Markillie LM, Taylor RC, Kim K, Weiss LM.The <em>Toxoplasma gondii</em> cyst wall protein CST1 is critical for cyst wall integrity and promotes bradyzoite persistence. PLoS Pathog. 2013 Dec;9(12):e1003823. doi: 10.1371/journal.ppat.1003823. PMID:24385904</p>
<p>Morada M, Lee S, Gunther-Cummins L, Weiss LM, Widmer G, Tzipori S, Yarlett N. Continuous culture of <em>Cryptosporidium parvum</em> using hollow fiber technology. Int J Parasitol. 2015 Sep 2. pii: S0020-7519(15)00220-9. doi: 10.1016/j.ijpara.2015.07.006. PMID: 26341006</p>
<p>Ma Y, Weiss LM, Huang H. Inducible suicide vector systems for <em>Trypanosoma cruzi</em>. Microbes Infect. 2015 Jun;17(6):440-50. doi: 10.1016/j.micinf.2015.04.003. Epub 2015 Apr 18. PMID: 25899945</p>
<p>Nardelli SC, Che FY, Silmon de Monerri NC, Xiao H, Nieves E, Madrid-Aliste C, Angel SO, Sullivan WJ Jr, Angeletti RH, Kim K, Weiss LM. The Histone Code of <em>Toxoplasma gondii</em> Comprises Conserved and Unique Posttranslational Modifications. mBio. 2013 Dec 10;4(6). doi:pii: e00922-13. 10.1128/mBio.00922-13. PMID:24327343</p>
<p>Pombert JF,Selman M,Burki F,Bardell FT,Farinelli L,Solter LF,Whitman DW,Weiss LM, Corradi N, Keeling PJ. Gain and loss of multiple functionally related, horizontally transferred genes in the reduced genomes of two microsporidian parasites. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12638-43. Epub 2012 Jul 16. PMID:22802648</p>
<p>Ghosh K, Nieves E, Keeling P, CaliA, Weiss LM. A new vesicular compartment in <em>Encephalitozoon cuniculi</em>. Microbes Infect. 2012 Apr;14(4):324-8. PMID:22166342</p>
<p>Ghosh K, Nieves E, Keeling P, Pombert JF, CaliA, Weiss LM. A branching network of proteinaceous filaments within the parasitophorous vacuole of<em> Encephalitozoon cuniculi</em> and <em>Encephalitozoon hellem</em>. Infect Immun. 2011 Jan 10. PMID: 21220485</p>
<p>Bouzahzah B, Nagajyothi F, Ghosh K, Takvorian PM, CaliA, Tanowitz HB, Weiss LM. Interactions of <em>Encephalitozoon cuniculi</em> polar tube proteins. Infect Immun. 2010 Jun;78(6):2745-53. Epub 2010 Mar 22. PMID: 20308291</p>
<p>Alvarado JJ, Nemkal A, Sauder JM, Russell M, Akiyoshi DE, Shi W, Almo SC, Weiss LM. Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470. Mol Biochem Parasitol. 2009 Aug 4. PMID: 19660503</p>
<p><strong>BOOKS</strong></p>
<p>Weiss LM and Kim K (eds.) <em>Toxoplasma gondii</em> the model Apicomplexan: Methods and Applications, Elsevier Press (Academic Press), 3rd edition, 2020.</p>
<p>Weiss LM and Reinke AW (eds.) Microsporidia: Current Advances in Biology, Springer, 2022.</p>
<p>Weiss LM and Becnel JJ (eds.) Microsporidia: Pathogens of Opportunity, Wiley-Blackwell, 2014.</p>
<p>Louis M. Weiss, MD, MPH, is Vice Chair, Academic Affairs and Research, Pathology, Co-Director, Einstein Global Health Center and Professor, Pathology and Medicine (Infectious Diseases) at Montefiore Einstein. His clinical expertise is in the treatment and diagnosis of infectious diseases, with a focus on parasitology and global health.</p><p>After obtaining his Bachelor of Arts in biology and chemistry from Lehigh University in 1978, Dr. Weiss earned his Doctor of Medicine and Master of Public Health at Johns Hopkins University in 1982. Following this, Dr. Weiss completed his internship and residency in medicine at the University of Chicago in 1985 and an infectious diseases fellowship at Einstein Montefiore in 1989.</p><p>Dr. Weiss investigates the biology of <em>Toxoplasma gondii</em> and its ability to cause latent infections, with a focus on the composition and structure of the <em>T. gondii</em> tissue cyst. He also investigates the biology of infection due to the microsporidia, with a focus on the composition of the polar tube and how it functions during microsporidian invasion of a host cell. His research has been published in numerous peer-reviewed journals, articles, books and chapters, and he has presented this research both nationally and internationally. Dr. Weiss has been a reviewer for scientific journals including <em>mBIO</em>, the <em>Journal of Eukaryotic Microbiology</em>, the <em>American Journal of Tropical Medicine and Hygiene, PLOS Pathogens</em>, the <em>Journal of Infectious Diseases</em> and <em>Experimental Parasitology</em>, and is an editor for <em>mBIO</em> and <em>Microbes and Infection</em>.</p><p>Dr. Weiss is board certified in Internal Medicine and Infectious Diseases. He is a Fellow of the Infectious Diseases Society of America, the American College of Physicians and the American Academy of Microbiology of the American Society of Microbiology. In 2000, Dr. Weiss was inducted into the Leo M. Davidoff Society for his outstanding teaching of medical students.</p>
<p>Dr. Torres completed his MD degree at Universidad del Valle (Cali, Colombia) in 2006. He then joined the International Center for Training and Medical Research (CIDEIM) in his home town, Cali, where he spent almost 3 years as a research assistant in the area of Gram negative Bacterial Resistance, where he published and presented his work in national and international journals and conferences.</p>
<p>After completing his Internal Medicine residency at Jacobi Medical Center in the Bronx, Dr. Torres completed his fellowship in Infectious Diseases at New York University (NYU). He then joined Englewood Hospital where he spent more than 2 years as an Infectious Disease consultant.</p>
<p>Dr. Torres joined Montefiore Medical Center/Albert Einstein College of Medicine in 2017 as an Assistant Professor. Since then, he has been providing PrEP, PEP, STI, HCV and HIV care to patients in the Bronx, as well as inpatient Infectious Disease consultation services at the hospital. He has an interest to expand HIV prevention projects in Colombia and is working closely with Corporacion de Lucha contra el SIDA in Cali.</p>
<p>Dr. Torres has been a member of the Infectious Disease Society of America since 2012.</p>
<p> </p>
<p> </p>
<p align="left"><strong><span style="font-family: Times New Roman; font-size: medium;">Selected Publications</span></strong><strong><span style="text-decoration: underline;"><span style="font-family: Times New Roman; font-size: medium;"><br /></span></span></strong></p>
<p class="MsoListParagraph" style="margin-left: .5in; text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in; background: white;"><!-- [if !supportLists]--><span lang="ES" style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;">Nori P, Szymczak W, Puius J, Sharma A, Cowman K, Fleischner Z, Bartash R, Chen V, Corpuz M, Gialanella P, Alpert P, Felsen U,<strong> Torres-Isasiga J</strong>, Guo Y. </span><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US;">Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing Enterobacterales Infections in New York City COVID-19 Patients. </span><span lang="ES" style="color: black; mso-color-alt: windowtext;">Int J Antimicrob Agents. 56(6):106179. doi: 10.1016/j.ijantimicag.2020.106179. Epub 2020 Sep 25.<strong> (2020)</strong></span></p>
<p class="MsoListParagraph" style="margin-left: .5in; text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in; background: white;"><!-- [if !supportLists]--><span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="ES" style="color: black; mso-color-alt: windowtext; mso-bidi-font-weight: bold;">Mueses-Marín HF, Alvarado-Llano B, </span><strong style="mso-bidi-font-weight: normal;"><span lang="ES" style="color: black; mso-color-alt: windowtext;">Torres-Isasiga J</span></strong><span lang="ES" style="color: black; mso-color-alt: windowtext; mso-bidi-font-weight: bold;">, Camargo-Plazas P, Bolívar-Rocha MC, Galindo-Orrego X, Martínez-Cajas JL. </span><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;">Scales to Assess Knowledge, Motivation, and Self-Efficacy for HIV PrEP in Colombian MSM: PrEP-COL Study. AIDS Research and Treatment, vol. 2021, Article ID 4789971, 11 pages </span><strong style="mso-bidi-font-weight: normal;"><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US;">(2021)</span></strong></p>
<p class="MsoListParagraph" style="margin-left: .5in; text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in; background: white;"><!-- [if !supportLists]--><span lang="ES" style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-bidi-font-weight: bold;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;">Falsey AR, et al., </span><strong style="mso-bidi-font-weight: normal;"><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US;">and the AstraZeneca AZD1222 Clinical Study Group (Julian A. Torres). </span></strong><span lang="ES" style="color: black; mso-color-alt: windowtext;"><a href="https://pubmed.ncbi.nlm.nih.gov/34587382/"><span lang="EN-US" style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US; mso-bidi-font-weight: bold; text-decoration: none; text-underline: none;">Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine</span></a></span><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;">. </span><span lang="ES" style="color: black; mso-color-alt: windowtext; mso-bidi-font-weight: bold;">N Engl J Med. </span><span lang="ES" style="font-size: 10.5pt; font-family: 'Segoe UI',sans-serif; color: #4d8055; background: white;"> </span><span lang="ES" style="color: black; mso-color-alt: windowtext; mso-bidi-font-weight: bold;">doi: 10.1056/NEJMoa21052902021. </span><strong style="mso-bidi-font-weight: normal;"><span lang="ES" style="color: black; mso-color-alt: windowtext;">(2021).</span></strong></p>
<p class="MsoListParagraph" style="margin-left: .5in; text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in; background: white;"><!-- [if !supportLists]--><span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="ES" style="color: black; mso-color-alt: windowtext; mso-bidi-font-weight: bold;">Martínez-Cajas J, Alvarado-Llano B, Martínez-Buitrago E, <strong>Torres-Isasiga J</strong>, Arrivillaga M, Camargo P, Galindo-Orrego X, Mueses-Marín H. </span><span lang="ES" style="color: black; mso-color-alt: windowtext;"><a href="https://pubmed.ncbi.nlm.nih.gov/35067114/"><span lang="EN-US" style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US; mso-bidi-font-weight: bold; text-decoration: none; text-underline: none;">AC-2020-12-1420.R1 - HIV care providers' familiarity, concerns, and attitudes about HIV PrEP in Colombia: insights from the PrEP-Col-Study.</span></a></span><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;"> AIDS Care. doi: 10.1080/09540121.2022.2029813 </span><strong style="mso-bidi-font-weight: normal;"><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US;">(2022)</span></strong></p>
<p class="MsoListParagraph" style="margin-left: .5in; text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in; background: white;"><!-- [if !supportLists]--><span style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="ES" style="color: black; mso-color-alt: windowtext; mso-bidi-font-weight: bold;">Martínez-Cajas JL, <strong>Torres J, </strong>Mueses HF, Camargo Plazas P, Arrivillaga M, Gomez SA, Galindo X, Martínez Buitrago E, Alvarado-Llano BE. </span><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US; mso-bidi-font-weight: bold;">Applying Implementation Science Frameworks to Identify Factors that Influence the Intention of Healthcare Providers to Offer PrEP Care and Advocate for PrEP in HIV Clinics in Colombia: A Cross-Sectional Study. Implement Sci Commun. Mar 16; 3(1):31. doi.org/10.1186/s43058-022-00278-2 </span><strong style="mso-bidi-font-weight: normal;"><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US;">(2022)</span></strong></p>
<p class="MsoListParagraph" style="margin-left: .5in; text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in; background: white;"><!-- [if !supportLists]--><span lang="ES" style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="color: black; mso-color-alt: windowtext; mso-ansi-language: EN-US;">Meyerowitz EA, Bernardo, RM, Collins-Ogle, MD, Mamber Czeresnia, J, Morales Matos, C, Mullis C, Root, H; <strong>Torres-Isasiga JA</strong>, Tsai, H; Zingman, B. Navigating HIV Screening Recommendations for People on PrEP and the Need to Update Testing Algorithms. </span><em><span lang="ES" style="color: black; mso-color-alt: windowtext;">Open Forum Infectious Diseases</span></em><span lang="ES" style="color: black; mso-color-alt: windowtext;">, ofac191. <a href="https://doi.org/10.1093/ofid/ofac191"><span style="color: black; mso-color-alt: windowtext; text-decoration: none; text-underline: none;">doi.org/10.1093/ofid/ofac191</span></a> <strong>(2022)</strong></span></p>
<p class="MsoListParagraph" style="margin-left: .5in; text-indent: -.25in; mso-list: l0 level1 lfo1; tab-stops: list .5in; background: white;"><!-- [if !supportLists]--><span lang="ES" style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">·<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span lang="ES-CO" style="color: black; mso-color-alt: windowtext; mso-ansi-language: ES-CO;">Arrivillaga M, Gómez SA, Mueses HF, Alvarado B, Martínez Buitrago E, Camargo-Plazas P, Hurtado LR, Bolívar MC, Galindo X, <strong>Torres J</strong>, Cajas-Martínez JL. Facilitadores y recomendaciones de proveedores de salud para la implementación de la Profilaxis Pre-Exposición en clínicas de VIH en Colombia. “Estudio PPrE-Colombia”. Rev Gerenc Polit Salud;21. </span><span lang="ES" style="color: black; mso-color-alt: windowtext;"><a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fdoi.o…; target="_blank" rel="noopener"><span lang="ES-CO" style="color: black; mso-color-alt: windowtext; mso-ansi-language: ES-CO; text-decoration: none; text-underline: none;">https://doi.org/10.11144/Javeriana.rgps21.frps</span></a></span><span lang="ES-CO" style="color: black; mso-color-alt: windowtext; mso-ansi-language: ES-CO;"> <strong>(2022)</strong></span></p>
<p class="MsoListParagraph" style="margin-left: 0.5in; text-indent: -0.25in; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"><!-- [if !supportLists]--><span lang="ES-CO" style="font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: ES-CO;">·<span style="font-variant-numeric: normal; font-variant-east-asian: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> </span></span><!--[endif]--><span lang="ES-CO">Meyerowitz EA, Gendlina I, Desai VJ, Grossberg R, Nair SR, Pujar B, Riska PF, Root HB, Toro J, <strong>Torres JA</strong>, Pirofski LA, Zingman BS. Anorectal Testing for Monkeypox Virus Infection in Men who have Sex with Men with and without Proctitis. Clin Infect Dis. 2022 Oct 13:ciac825. doi: 10.1093/cid/ciac825. Epub ahead of print. PMID: 36227656 <strong>(2022)</strong></span></p>
<p>Julian A. Torres lsasiga, MD, is an attending physician at Montefiore Einstein and Associate Professor, Infectious Diseases at our Albert Einstein College of Medicine. Dr. Torres’s clinical focus centers on general infectious disease care, HIV prevention and care, sexually transmitted infections and medical education.</p><p>After earning his Doctor of Medicine at the Universidad del Valle/Hospital Universitario del Valle in Cali, Colombia in 2006, Dr. Torres became a research assistant at the International Center for Medical Research and Training (CIDEIM) in Cali, Colombia, from 2007 to 2009. He then moved to the United States to continue his medical training, completing his internal medicine residency at Jacobi Medical Center in 2012 and an infectious disease fellowship at New York University in 2014.</p><p>Building on his clinical focus, Dr. Torres’s research is focused on HIV prevention and pre-exposure prophylaxis (PrEP). He has been co-investigator, principal investigator and sub-investigator on several research projects and he has shared his work through many national and international invited presentations and poster presentations. Dr. Torres is a reviewer for <em>Clinical Infectious Disease, Open Forum Infectious Disease</em> and the <em>International Journal of STD & AIDS</em>. His work has been published in numerous peer-reviewed journals, books, chapters, review articles and abstracts.</p><p>Dr. Torres is board certified in Internal Medicine and Infectious Disease by the American Board of Internal Medicine. He is a member of the Infectious Disease Society of America. In 2023, he received the Excellence in Teaching Award from the Division of Infectious Disease at Montefiore Einstein. The same year, Dr. Torres received the Teaching Star-Teaching Commendation Letter for the 2022-2023 Academic Year from Montefiore Einstein.</p>
<p>My research interests are: Clostridium difficile, Tuberculosis, Molecular epidemiology, Molecular mechanisms of antibiotic resistance, Bacteriophage Therapy. </p>
<p>Dr. Yoram Puius completed MD and PhD degrees at the Albert Einstein College of Medicine in 2001. His original research was in the structural biology of signal transduction proteins in the laboratory of Dr. Steven Almo. After completing a residency in Internal Medicine at New York Hospital, he completed a fellowship in Infectious Diseases at Columbia Presbyterian, followed by an additional year at Tufts Medical Center focusing on infections in transplant recipients.</p>
<p>Dr. Puius's first position was at Roger Williams Medical Center in Providence, Rhode Island in 2007. There he served as Medical Director of Infection Control and Assistant Program Director of the Internal Medicine Residency, while holding the rank of Assistant Professor at Boston University School of Medicine. In Rhode Island he further developed interest and expertise in tickborne diseases. In addition, he directed infectious diseases protocols and education for the sole Bone Marrow Transplant Unit in the state of Rhode Island. </p>
<p>Since joining Einstein-Montefiore in 2011, Dr. Puius has worked closely with transplant teams providing inpatient and outpatient consultations, working on protocols for various selection committees, and developing an online transplant infections curriculum. He was promoted to the rank of Associate Professor in 2018. He has also served as Associate Program Director for the Fellowship in Infectious Diseases. He remains clinically active in the evaluation and treatment of tickborne diseases.</p>
<p>Dr. Puius is a member of the Infectious Diseases Society of America, the American Society for Transplantation, the Transplantation Society, and the International Society for Heart and Lung Transplantation. He is on the editorial boards of <em>Clinical Transplantation</em> and <em>Transplant Infectious Diseases</em>, and a reviewer for several other journals.</p>
<p>He publishes and speaks regionally on infections in the immunocompromised host and Lyme disease. He also chairs the working group to maintain the online Transplant Infectious Diseases library for the American Society of Transplantation (AST) ID Community of Practice, at http://transplantid.net/. In addition, he initatied a working group for AST to create standardized patient materials for safe living after transplantation. In 2024 he was selected as a Fellow of the American Society of Transplantation.</p>
<p>Clinical Interests:</p>
<p>- Infections in the immunocompromised host, including recipients of kidney, liver, heart, and stem cell transplants</p>
<p>- Infections in patients with hematological malignancies</p>
<p>- Infections in patients with Left Ventricular Assist Devices</p>
<p>- Lyme disease</p>
<p>- Pre-travel counseling and vaccination for the immunocompromised patient</p>
<p>- Online educational resources in transplant infectious diseases</p>
<p> </p>
Treating infections in the immunocompromised host, including recipients of solid organ transplants, patients with hematologic malignancies and recipients of cellular therapy.
Infections in left ventricular assist device recipients, heart transplant recipients and kidney transplant recipients.
<p class="MsoNormal" style="margin-left: .25in; text-indent: -.25in; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span style="font-size: 10pt;"><span style="mso-list: Ignore;">1.<span style="font-style: normal; font-variant: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-stretch: normal; font-size: 7pt; line-height: normal; font-family: 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Levin, S., Mayer, D., <strong>Puius, Y.A.</strong>, Arora, S., and Gileles-Hillel A. (2024) Things We Do for No Reason™: Routine respiratory pathogen panels for emergency department and hospitalized patients.<span style="mso-spacerun: yes;"> </span><em>J. Hosp. Med.</em> </span><a href="https://doi.org/10.1002/jhm.13365"><span style="font-size: 10.0pt;">https://doi.org/10.1002/jhm.13365</span></a></p>
<p class="MsoNormal" style="margin-left: .25in;"><span style="font-size: 10pt;"> </span></p>
<p class="MsoNormal" style="margin-left: .25in; text-indent: -.25in; mso-list: l0 level1 lfo1;"><span style="font-size: 10pt;"><span style="mso-list: Ignore;">2. </span></span><span style="font-size: 10.0pt;">Mullis, C.E., Heldman, M., Bahr, N.C., Minamoto, G.Y., <strong>Puius. Y.A.</strong>, and Malinis, M. (2024) Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient. <em>Transpl Infect Dis</em>. </span><a href="https://doi.org/10.1111/tid.14271"><span style="font-size: 10.0pt;">https://doi.org/10.1111/tid.14271</span></a></p>
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify;"><span style="font-size: 10.0pt;"> </span></p>
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Coe J., <strong>Puius, Y.</strong>, Jain, H., and Meyerowitz, E. (2024) Cervical lymphadenitis from <em>Mycobacterium avium</em> complex.<span style="mso-spacerun: yes;"> </span><em>BMJ Case Reports</em>.</span> <strong><span style="font-size: 10.0pt;">17</span></strong><span style="font-size: 10.0pt;">(3):e256726. <span style="mso-spacerun: yes;"> </span></span><a href="https://doi.org/10.1136/bcr-2023-256726"><span style="font-size: 10.0pt;">https://doi.org/10.1136/bcr-2023-256726</span></a></p>
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify;"><span style="font-size: 10.0pt;"> </span></p>
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">4.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Arora, S. and <strong>Puius, Y.A.</strong> (2023) Comment on: Community-Acquired Pneumonia.<span style="mso-spacerun: yes;"> </span><em>N Engl J Med</em> <strong>389</strong>(17): 1633. </span><a href="https://doi.org/10.1056/nejmc2310748"><span style="font-size: 10.0pt;">https://doi.org/10.1056/nejmc2310748</span></a></p>
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify;"><span style="font-size: 10.0pt;"> </span></p>
<p class="MsoListParagraph" style="margin-left: .25in; text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">5.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Tsai, H., Minamoto, G.Y., and <strong>Puius, Y.A</strong>. (2023) "Chapter 36. Infections in Heart Transplantation" In: Barac, Y.D., Silvestry, S.C., Goldstein, D., Daneshmand M.A. eds. Textbook of Transplantation and Mechanical Support for End-Stage Heart and Lung Disease. Wiley-Blackwell.</span></p>
<p class="MsoListParagraph" style="margin-left: .25in;"><span style="font-size: 10.0pt;"> </span></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span class="MsoHyperlink"><span style="font-size: 10.0pt; color: windowtext; text-decoration: none; text-underline: none;"><span style="mso-list: Ignore;">6.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Gould, C.V., Free, R.J., Bhatnagar, J. et al. (2023) Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation, United States, 2021 – Report of an Investigation. <em>Lancet Microbe</em>. <strong>4</strong>(9):e711-e721.<span style="mso-spacerun: yes;"> </span></span><a href="https://doi.org/10.1016/S2666-5247(23)00170-2"><span style="font-size: 10.0pt;">https://doi.org/10.1016/S2666-5247(23)00170-2</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">7.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Azar, M.M., Tsai, H., Vergidis, P., Harris, C.E., Anjan, S., Barros,N., Belga, S., Chuang, S.T., Czeresnia, J.M., Goel, S., Ince, D., Luk, A., Majeed, A., Multani, A., Obedi, K.M., and Swaminathan, N. (2023) <em>transplantid.net</em>:<span style="mso-spacerun: yes;"> </span>A Pilot Crowdsourced, Living, Online Library of Resources for the Teaching and Practice of Transplant Infectious Diseases. <em>Open Forum Inf Dis.</em></span> <strong><span style="font-size: 10.0pt;">10</span></strong><span style="font-size: 10.0pt;">(2):ofad081.</span> <a href="https://doi.org/10.1093/ofid/ofad081"><span style="font-size: 10.0pt;">https://doi.org/10.1093/ofid/ofad081</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span class="MsoHyperlink"><span style="font-size: 10.0pt; color: windowtext; text-decoration: none; text-underline: none;"><span style="mso-list: Ignore;">8.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Hemmige, V., Saeed, O., <strong>Puius, Y.A.</strong>, Azzi, Y., Colovai, A., Borgi, J., Goldstein, D.J., Rahmanian, M., Carlese, A., Jorde, U.P., and Patel, S. (2023)<span style="mso-spacerun: yes;"> </span>HIV D+/R+ heart/kidney transplantation: first case report. <em>J Heart Lung Transplant</em>.</span> <strong><span style="font-size: 10.0pt;">42</span></strong><span style="font-size: 10.0pt;">(3):406-408. </span><a href="https://doi.org/10.1016/j.healun.2022.11.004"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.healun.2022.11.004</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">9.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Maini, R., Saini, N., Bhavaan, K., Bharti, B., Walia, S., Kori N., Kataria S., Sharma P., Deswal V., Atluri, K., Mandke C, Chansoria M., Rawat, S.K., Bhat, R.S., Dravid, A., Barnawal, C., Sarkar N., Jariwala S., <strong>Puius, Y.A</strong>., Arora, S., Sethi, Y, for the MUNCO Registry. (2022) Clinico-epidemiologic characteristics of patients reported in the Mycotic infections in COVID-19 Registry. <em>Am J Trop Med Hygiene </em><strong>108</strong>(3):584-587<em>.</em> </span><a href="https://doi.org/10.4269/ajtmh.22-0503"><span style="font-size: 10.0pt;">https://doi.org/10.4269/ajtmh.22-0503</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">10.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Arora, S., Narayanan, S., Fazzari, M., Bhavana, K., Bhartendu, B., Walia, S., Kori N., Kataria S., Sharma P., Atluri, K., Mandke C, Gite, V., Redkar, N., Chansoria M., Rawat, S.K., Bhat, R.S., Dravid, A., Sethi, Y., Barnawal, C., Sarkar N.K., Jariwala S., Southern, W., <strong>Puius, Y.A.</strong>, MUNCO Registry (2022) Factors Associated with Mortality in Coronavirus-Associated Mucormycosis: Results from Mycotic Infections in COVID-19 (MUNCO) Online Registry. <em>J Clin Med</em>. <strong>11</strong>(23):7015.<span style="mso-spacerun: yes;"> </span></span><a href="https://doi.org/10.3390/jcm11237015"><span style="font-size: 10.0pt;">https://doi.org/10.3390/jcm11237015</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">11.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Castagna F., Xue X., Saeed O., et al. (2022) Hospital bed occupancy rate is an independent risk factor for COVID-19 inpatient mortality: a pandemic epicentre cohort study. <em style="mso-bidi-font-style: normal;">BMJ Open</em>. 12(2):e058171. </span><a href="https://doi.org/10.1136/bmjopen-2021-05817"><span style="font-size: 10.0pt;">https://doi.org/10.1136/bmjopen-2021-05817</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">12.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Thakkar, A., Cui, Z., Peeke, S.Z., et al. (2021) Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world setting.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Stem Cell Investig</em>. 8:18. </span><a href="https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8449156/"><span style="font-size: 10.0pt;">https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8449156/</span></a></…;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">13.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Arora, S., Hemmige, V.S., Mandke, C., Chansoria, M., Rawat, S.K., Dravid, A., Sethi, Y., Medikeri, G., Jariwala, S.P., and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong> (2021) Online registry of COVID-19–associated mucormycosis cases, India, 2021. <em style="mso-bidi-font-style: normal;">Emerg Infect Dis</em>.<strong style="mso-bidi-font-weight: normal;">27</strong>(11) </span><a href="https://wwwnc.cdc.gov/eid/article/27/11/21-1322_article"><span style="font-size: 10.0pt;">https://wwwnc.cdc.gov/eid/article/27/11/21-1322_article</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">14.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Bartash, R. M., and Zingman, B. S. (2021) Maintaining Mask Momentum in Transplant Recipients.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Transplant Infectious Disease</em> <strong style="mso-bidi-font-weight: normal;">23</strong>(4): e13697. </span><a href="https://doi.org/10.1111/tid.13697"><span style="font-size: 10.0pt;">https://doi.org/10.1111/tid.13697</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">15.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Cervera Hernandez, M.E., Szymczak, W., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, and Shuter, J. (2021) Lung, Brain, and Spinal Cord Abscesses After a Near-Drowning Episode.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">American J. Med.</em> </span><a href="https://doi.org/10.1016/j.amjmed.2021.04.039"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.amjmed.2021.04.039</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">16.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Parkar, F., Tlamsa, A.P., Nistico, J.A., Muggia, V.A., Minamoto, G.Y., Jorde, U.P., Goldstein, D.J., and Moadel, R. (2021) Gallium-67 Single Photon Emission Computed Tomography Affects Management of Infections of Left Ventricular Assist Devices.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">ASAIO Journal. </em><strong style="mso-bidi-font-weight: normal;">67</strong>(7):<span style="mso-spacerun: yes;"> </span>746-751<span style="mso-spacerun: yes;"> </span></span><a href="https://doi.org/10.1097/mat.0000000000001316"><span style="font-size: 10.0pt;">https://doi.org/10.1097/mat.0000000000001316</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">17.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Muggia, V.A. and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong><span style="mso-spacerun: yes;"> </span>(2020) <em style="mso-bidi-font-style: normal;">Nocardia ignorata</em> Infection in Heart Transplant Patient.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Emerging Infectious Diseases</em> <strong style="mso-bidi-font-weight: normal;">26</strong>(11):2788-2789. </span><a href="https://doi.org/10.3201/eid2611.202756"><span style="font-size: 10.0pt;">https://doi.org/10.3201/eid2611.202756</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">18.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Nori, P., Szymczak, W., <strong style="mso-bidi-font-weight: normal;">Puius, Y</strong>., Sharma, A., Cowman, K., Gialanella, P., Fleischner, Z., Corpuz, M., Torres-Isasiga, J., Bartash, R., Felsen, U., Chen, V., and Guo, Y. (2020) Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing <em style="mso-bidi-font-style: normal;">Enterobacterales</em> Infections in New York City COVID-19 Patients. <em style="mso-bidi-font-style: normal;">Int. J. Antimicrobial Agents</em> <strong style="mso-bidi-font-weight: normal;">56</strong>(6):106179<span style="mso-spacerun: yes;"> </span></span><a href="https://doi.org/10.1016/j.ijantimicag.2020.106179"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.ijantimicag.2020.106179</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">19.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Peraza, J. and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong> (2020) Cutaneous Fungal Infections in Left Ventricular Assist Device Recipients. <em style="mso-bidi-font-style: normal;">Current Fungal Infection Reports</em>.</span> <strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">14</span></strong><span style="font-size: 10.0pt;">:225–232 </span><a href="https://rdcu.be/b4HaA"><span style="font-size: 10.0pt; background: white; mso-highlight: white;">https://rdcu.be/b4HaA</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">20.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Zheng, C., Quintero, O. Revere, E.K., Oey, M.B., Espinoza, F., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, Ramirez-Baron, D., Salama, C.R., Hidalgo, L.F., Machado, F.S., Saeed, O., Shun, J., Patel, S.R., Coyle, C.M., and Tanowitz, H.B. (2020) Chagas Disease in the New York City Metropolitan Area.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Open Forum Infectious Diseases</em> <strong style="mso-bidi-font-weight: normal;">7</strong>(5):</span> <span style="font-size: 10.0pt;">ofaa156. </span><a href="https://doi.org/10.1093/ofid/ofaa156"><span style="font-size: 10.0pt;">https://doi.org/10.1093/ofid/ofaa156</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">21.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.,</span></strong><span style="font-size: 10.0pt;"> Aldrich, M., and Cope, J.R.<span style="mso-spacerun: yes;"> </span>(2020) “Acanthamoeba, Naegleria, & Balamuthia in Transplant patients: An Emerging Threat.” In: Morris, M., Kotton, C., Wolfe, C. (eds) Emerging Transplant Infections, pp. <span style="mso-spacerun: yes;"> </span>1451-1472 Springer, Cham, Switzerland.<span style="mso-spacerun: yes;"> </span></span><a href="https://link.springer.com/referenceworkentry/10.1007%2F978-3-030-01751-… style="font-size: 10.0pt; background: white; mso-highlight: white;">https://link.springer.com/referenceworkentry/10.1007%2F978-3-030-01751-…;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">22.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Quintero Cardona, O., Hemmige, V., and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong><span style="mso-spacerun: yes;"> </span>(2020) Methenamine Hippurate May Have Particular Benefit in Preventing Recurrent Urinary Tract Infections in Diabetic Renal Transplant Recipients. <em style="mso-bidi-font-style: normal;">Transplant Infectious Diseases,</em> <strong style="mso-bidi-font-weight: normal;">22</strong>(2): e13247 </span><a href="https://doi.org/10.1111/tid.13247"><span style="font-size: 10.0pt;">https://doi.org/10.1111/tid.13247</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">23.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Jorde, U.P., Shah, A.M., Sims, D.B., Madan, S., Siddiqi, N., Luke, A., Saeed, O., Patel, S.R., Murthy S., Shin, J., Oviedo, J., Watts, S., Jakobleff, W., Forest, S., Vukelic, S., Belov, D., <strong style="mso-bidi-font-weight: normal;">Puius, Y.</strong>, Minamoto, G., Muggia, V., Carlese, A., Leung, S., Rahmanian, M., Leff, J., Goldstein, D. (2019) Continuous-flow left ventricular device survival improves with multidisciplinary approach.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Annals of Thoracic Surgery</em>. <strong style="mso-bidi-font-weight: normal;">108</strong>(2):508-516. </span><a href="https://doi.org/10.1016/j.athoracsur.2019.01.063"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.athoracsur.2019.01.063</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">24.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Patel S.R., Madan, S., Saeed, O., Sims D.B., Shin, J.J., Nucci, C., Borukhov, E., Goldstein, D.Y., Jakobleff, W., Forest, S., Vukelic, S., Murthy, S., Reinus, J., <strong style="mso-bidi-font-weight: normal;">Puius, Y</strong>., Goldstein, D.J., Jorde, U.P. (2018)<span style="mso-spacerun: yes;"> </span>Cardiac transplantation from non-viremic hepatitis C donors. <em style="mso-bidi-font-style: normal;">J Heart Lung Transplant</em>. <strong style="mso-bidi-font-weight: normal;">37</strong>(10): 1254-1260. </span><a href="https://doi.org/10.1016/j.healun.2018.06.012"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.healun.2018.06.012</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">25.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt; color: black;">Mogollón, J.E., Szymczak, W.A., Levi, M.H., Patel, H., and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A</strong>. (2018) Case #17015: Renal recipient with two weeks of progressive shortness of breath, fatigue, and bilateral lower extremity swelling. <em style="mso-bidi-font-style: normal;">Partners Infectious Disease Images</em>, </span><a href="https://www.idimages.org/idreview/case/?CaseID=544"><span style="font-size: 10.0pt;">https://www.idimages.org/idreview/case/?CaseID=544</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">26.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt; color: black;">Muggia, V.A., Minamoto, G.Y., Forest, S.J., Lerman, D.T., and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong> (2018)<span style="mso-spacerun: yes;"> </span>“Chapter 3:<span style="mso-spacerun: yes;"> </span>Left Ventricular Assist Device Infections: A Practical Approach.”<span style="mso-spacerun: yes;"> </span>In:<span style="mso-spacerun: yes;"> </span>Ventricular Assist Devices: Management, Outcomes and Complications.<span style="mso-spacerun: yes;"> </span>René Murielle, ed.<span style="mso-spacerun: yes;"> </span>Nova Science Publishers., Inc., Happauge, NY. </span><a href="https://novapublishers.com/wp-content/uploads/2019/01/978-1-53613-891-7… style="font-size: 10.0pt;">https://novapublishers.com/wp-content/uploads/2019/01/978-1-53613-891-7…;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">27.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Kutner, A., Aldrich, M. Patel, S. Kang, J. J., Amin, B. Mann, R., Ali I. M., Brasil Martines, R., Cope, J. R., De Boccardo, G. O., and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong> (2018)<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Acanthamoeba</em> Endophthalmitis During Treatment for Cutaneous Disease in a Renal Transplant Patient.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Transplant Infectious Diseases</em>, <strong style="mso-bidi-font-weight: normal;">20</strong>(2):e12483 </span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6110267/"><span style="font-size: 10.0pt;">http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6110267/</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">28.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Levy, D.T., Peck, N., Minamoto, G.Y., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, D’Alessandro, D.A., Goldstein, D. and Muggia, V.A.<span style="mso-spacerun: yes;"> </span>(2015)<span style="mso-spacerun: yes;"> </span>Role of gallium SPECT-CT in the diagnosis of left ventricular assist device infections:<span style="mso-spacerun: yes;"> </span>A case series and review of the literature.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">ASAIO Journal</em>, <strong style="mso-bidi-font-weight: normal;">61</strong>(1):<span style="mso-spacerun: yes;"> </span>e5-e10. </span><a href="https://doi.org/10.1097/mat.0000000000000167"><span style="font-size: 10.0pt;">https://doi.org/10.1097/mat.0000000000000167</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">29.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Levy, D.T., Guo, Y., Simkins, J., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, Muggia, V.A., Goldstein, D.J., D'Alessandro, D.A., and Minamoto, G.Y. (2014) Left ventricular assist device exchange for persistent infection: a case series and review of the literature. <em style="mso-bidi-font-style: normal;"><span style="color: black;">Transplant Infectious Diseases</span></em><span style="color: black;">, <strong style="mso-bidi-font-weight: normal;">16</strong>(3): 453-460. </span></span><a href="https://doi.org/10.1111/tid.12207"><span style="font-size: 10.0pt;">https://doi.org/10.1111/tid.12207</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; font-variant: small-caps;"><span style="mso-list: Ignore;">30.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt; color: black;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt; color: black;">, Sonder, G. B., and Mileno, M. (2013)<span style="mso-spacerun: yes;"> </span>“Chapter 27:<span style="mso-spacerun: yes;"> </span>The Immunocompromised Traveler”<span style="mso-spacerun: yes;"> </span>In:<span style="mso-spacerun: yes;"> </span>Travel Medicine, 3<sup>rd</sup> Edition, Jay Keystone, Ed., pp. 265-272.<span style="mso-spacerun: yes;"> </span>Elsevier. </span><a href="https://www.sciencedirect.com/science/article/pii/B9781455710768000272"… style="font-size: 10.0pt;">https://www.sciencedirect.com/science/article/pii/B9781455710768000272<…;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; font-variant: small-caps;"><span style="mso-list: Ignore;">31.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt; color: black;">Irizarry-Acosta, M. and <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong> (2010) Post-influenza pneumonia:<span style="mso-spacerun: yes;"> </span>Everything old is new again.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Medicine and Health in Rhode Island,</em> <strong style="mso-bidi-font-weight: normal;">93</strong>: 204-211. </span><a href="http://www.rimed.org/medhealthri/2010-07/2010-07-204.pdf"><span style="font-size: 10.0pt;">http://www.rimed.org/medhealthri/2010-07/2010-07-204.pdf</span></a></p&…;
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">32.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt; color: black;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt; color: black;"> and Kalish, R.A. (2008) Lyme Arthritis:<span style="mso-spacerun: yes;"> </span>Pathogenesis, Clinical Presentation, and Management.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Infectious Disease Clinics of North America</em>, <strong style="mso-bidi-font-weight: normal;">22</strong>: 289-300. </span><a href="https://doi.org/10.1016/j.idc.2007.12.014"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.idc.2007.12.014</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">33.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt; color: black;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt; color: black;">, Shah, D.P., Brust, D.G., Dove, L.M., and Lefkowitch, J.H.<span style="mso-spacerun: yes;"> </span>(2008) Three Cases of Autoimmune Hepatitis in HIV Infected Patients.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Journal of Clinical Gastroenterology</em>, <strong style="mso-bidi-font-weight: normal;">42</strong>:<span style="mso-spacerun: yes;"> </span>425-429. </span><a href="https://doi.org/10.1097/01.mcg.0000225591.08825.3e"><span style="font-size: 10.0pt;">https://doi.org/10.1097/01.mcg.0000225591.08825.3e</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">34.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt; color: black;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt; color: black;"> and Snydman, D.R. (2007) Prophylaxis and treatment of CMV disease in recipients of solid organ transplants:<span style="mso-spacerun: yes;"> </span>Current approach and future challenges.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Current Opinion in Infectious Diseases</em> <strong style="mso-bidi-font-weight: normal;">20</strong>:<span style="mso-spacerun: yes;"> </span>419-424. </span><a href="https://doi.org/10.1097/qco.0b013e32821f6026"><span style="font-size: 10.0pt;">https://doi.org/10.1097/qco.0b013e32821f6026</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">35.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt; color: black;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt; color: black;"> and Scully, B. (2007) Treatment of <em style="mso-bidi-font-style: normal;">Candida albicans</em> pericarditis in a heart transplant patient.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Transplant Infectious Diseases</em> <strong style="mso-bidi-font-weight: normal;">9</strong>:<span style="mso-spacerun: yes;"> </span>229-232. </span><a href="https://doi.org/10.1111/j.1399-3062.2006.00195.x"><span style="font-size: 10.0pt;">https://doi.org/10.1111/j.1399-3062.2006.00195.x</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">36.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Stievater, T.H., and Srikrishnan, T. (2006) Crystal structure, conformation, and absolute configuration of kanamycin A.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Carbohydrate Research</em> <strong style="mso-bidi-font-weight: normal;">341</strong>:<span style="mso-spacerun: yes;"> </span>2871-2875. </span><a href="https://doi.org/10.1016/j.carres.2006.09.008"><span style="font-size: 10.0pt;">https://doi.org/10.1016/j.carres.2006.09.008</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">37.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt; color: black;">Dewan, J.C., Feeling-Taylor, A., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, Patskovska, L., Patskovsky, Y., Nagel, R.L., Almo, S.C., and Hirsch, R.E.</span> <span style="font-size: 10.0pt; color: black;">(2002) Structure of mutant human carbonmonoxyhemoglobin C (βE6K) at 2.0 Å resolution.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Acta Crystallographica</em> <strong style="mso-bidi-font-weight: normal;">D58</strong>:<span style="mso-spacerun: yes;"> </span>2038-2042. </span><a href="https://doi.org/10.1107/s0907444902016426"><span style="font-size: 10.0pt;">https://doi.org/10.1107/s0907444902016426</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">38.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><span style="font-size: 10.0pt;">Sarmiento, M., <strong style="mso-bidi-font-weight: normal;">Puius, Y.A.</strong>, Vetter, S.W., Keng, Y.-F., Wu, L., Zhao, Y., Lawrence, D.S., Almo, S.C., and Zhang, Z.-Y.<span style="mso-spacerun: yes;"> </span>(2000) Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Biochemistry</em> <strong style="mso-bidi-font-weight: normal;">39</strong>:<span style="mso-spacerun: yes;"> </span>8171-8179. </span><a href="https://doi.org/10.1021/bi000319w"><span style="font-size: 10.0pt;">https://doi.org/10.1021/bi000319w</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">39.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Fedorov, E.V., Eichinger, L., Schleicher, M., and Almo, S.C. (2000) Mapping the functional surface of domain 2 in the gelsolin superfamily.<span style="mso-spacerun: yes;"> </span><em style="mso-bidi-font-style: normal;">Biochemistry</em> <strong style="mso-bidi-font-weight: normal;">39</strong>:<span style="mso-spacerun: yes;"> </span>5322-5331. </span><a href="https://doi.org/10.1021/bi992364d"><span style="font-size: 10.0pt;">https://doi.org/10.1021/bi992364d</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">40.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Zou, M., Ho, N.T., Ho, C., and Almo, S.C. (1998) Novel water-mediated hydrogen bonds as the structural basis for the low oxygen affinity of the blood substitute candidate rHb(α96Val</span><span style="font-size: 10.0pt; font-family: Cardo; mso-fareast-font-family: Cardo; mso-bidi-font-family: Cardo;">→Trp). </span><em style="mso-bidi-font-style: normal;"><span style="font-size: 10.0pt;">Biochemistry</span></em><span style="font-size: 10.0pt;"> <strong style="mso-bidi-font-weight: normal;">37</strong>:<span style="mso-spacerun: yes;"> </span>9258-65. </span><a href="https://doi.org/10.1021/bi9727287"><span style="font-size: 10.0pt;">https://doi.org/10.1021/bi9727287</span></a></p>
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">41.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Mahoney, N.M., and Almo, S.C. (1998) The modular structure of actin-regulatory proteins.<em style="mso-bidi-font-style: normal;"> Current Opinion in Cell Biology </em><strong style="mso-bidi-font-weight: normal;"><span style="mso-spacerun: yes;"> </span>10:</strong> 23-34. </span><a href="https://doi.org/10.1016/s0955-0674(98)80083-5"><span style="font-size: 10.0pt;">https://doi.org/10.1016/s0955-0674(98)80083-5</span></a></p>
<div style="mso-element: para-border-div; border: none; border-bottom: solid black 1.0pt; mso-border-bottom-alt: solid black .5pt; padding: 0in 0in 1.0pt 0in;">
<p class="MsoNormal" style="text-align: justify; text-indent: -.25in; mso-list: l0 level1 lfo1; border: none; mso-border-bottom-alt: solid black .5pt; padding: 0in; mso-padding-alt: 0in 0in 1.0pt 0in; margin: 0in 0in 12.0pt .25in;"><!-- [if !supportLists]--><span style="font-size: 10.0pt;"><span style="mso-list: Ignore;">42.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span style="font-size: 10.0pt;">Puius, Y.A.</span></strong><span style="font-size: 10.0pt;">, Zhao, Y., Sullivan, M., Lawrence, D.S., Almo, S.C., and Zhang, Z.-Y. (1997) Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. <em style="mso-bidi-font-style: normal;"><span style="mso-spacerun: yes;"> </span>Proceedings of the National Academy of Sciences of the U.S.A. </em><strong style="mso-bidi-font-weight: normal;"><span style="mso-spacerun: yes;"> </span>94:</strong> 13420-13425. </span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/pmc28320/"><span style="font-size: 10.0pt;">http://www.ncbi.nlm.nih.gov/pmc/articles/pmc28320/</span></a></p>
</div>
<p>Yoram A. Puius, MD, PhD, is an attending physician, Associate Professor, Medicine and Associate Professor, Cardiothoracic & Vascular Surgery at Montefiore Einstein. His clinical focus centers on treating infections in the immunocompromised host, including recipients of solid organ transplants, patients with hematologic malignancies and recipients of cellular therapy.</p><p>After obtaining his Bachelor of Arts in physics from Cornell University in 1992, Dr. Puius earned his Doctor of Philosophy in biochemistry at Einstein in 1999, followed by his Doctor of Medicine in 2001. He moved to NewYork-Presbyterian Hospital-Cornell to complete his internal medicine residency in 2003 and an infectious diseases fellowship at NewYork-Presbyterian Hospital-Columbia in 2006. Following this, Dr. Puius completed an additional year focusing on infectious in the immunocompromised host at Tufts Medical Center in 2007.</p><p>Building on his clinical focus, Dr. Puius’s research involves infections in left ventricular assist device recipients, heart transplant recipients and kidney transplant recipients. In addition, he is the architect of the online transplant infectious disease library, “transplantid.net” for the American Society of Transplantation. He is also involved in research on COVID-19-associated Mucormycosis. Dr. Puius’s work has been published in numerous peer-reviewed journals, books, chapters and review articles, and he has presented abstracts and poster presentations nationally. He has been a reviewer for a number of journals and is on the editorial boards of <em>Clinical Transplantation</em> and <em>Transplant Infectious Diseases</em>.</p><p>Dr. Puius is board certified in Internal Medicine and Infectious Diseases. He is a member of many professional organizations, including the Infectious Diseases Society of America, the American Society of Transplantation and the International Society for Heart and Lung Transplantation. He is also the Founding Chair of the Transplant Infectious Diseases Online Library Working Group for the American Society of Transplantation. In 2021, Dr. Puius was named Heart Failure & Transplant Consultant of the Year at Montefiore. He has also been named in Castle Connolly’s “Top Doctors” for multiple years.</p>